Cargando…
Nanoliposome C6‐Ceramide in combination with anti‐CTLA4 antibody improves anti‐tumor immunity in hepatocellular cancer
Combination therapy represents an effective therapeutic approach to overcome hepatocellular cancer (HCC) resistance to immune checkpoint blockade (ICB). Based upon previous work demonstrating that nanoliposome C6‐ceramide (LipC6) not only induces HCC apoptosis but also prevents HCC‐induced immune to...
Autores principales: | Qi, Xiaoqiang, Wu, Feng, Kim, Sung Hoon, Kaifi, Jussuf T., Kimchi, Eric T., Snyder, Helena, Illendula, Anuradha, Fox, Todd, Kester, Mark, Staveley‐O'Carroll, Kevin F., Li, Guangfu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297193/ https://www.ncbi.nlm.nih.gov/pubmed/35294071 http://dx.doi.org/10.1096/fj.202101707R |
Ejemplares similares
-
Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice
por: Li, Guangfu, et al.
Publicado: (2018) -
Sunitinib and Sorafenib Modulating Antitumor Immunity in Hepatocellular Cancer
por: Liu, Dai, et al.
Publicado: (2018) -
Synergizing sunitinib and radiofrequency ablation to treat hepatocellular cancer by triggering the antitumor immune response
por: Qi, Xiaoqiang, et al.
Publicado: (2020) -
Ceramide Nanoliposomes as Potential Therapeutic Reagents for Asthma
por: Sakae, Harumi, et al.
Publicado: (2023) -
Western diet contributes to the pathogenesis of non-alcoholic steatohepatitis in male mice via remodeling gut microbiota and increasing production of 2-oleoylglycerol
por: Yang, Ming, et al.
Publicado: (2023)